Article

A Qualitative Research Exploring the Experiences of Patients Receiving Immune Checkpoint Inhibitors for Advanced Lung Cancer

2023-02-14

Abstract excerpt

<h4>Purposes: </h4> In patients with advanced lung cancer, immune checkpoint inhibitors (ICIs) dramatically extended survival. We aimed to investigate the experiences of patients with advanced lung cancer who are receiving ICIs, with a focus on perceptions and sentiments on ICIs, to inform future research and clinical care. <h4>Methods: </h4>: Patients were recruited from January - July 2022 at Tianjin Medical Un...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ed1558e9-e75c-5640-8e41-380e8ffca003
DOI: 10.21203/rs.3.rs-2571647/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Qualitative Research Exploring the Experiences of Patients Receiving Immune Checkpoint Inhibitors for Advanced Lung CancerDOI 10.21203/rs.3.rs-2571647/v1Read

Oncological therapy in stage IV lung cancer patients at the end-of-life – A retrospective single-center cohort analysis in the era of tyrosine kinase inhibition and immunotherapySemantic proximity Read

Comparative Safety of Immune Checkpoint Inhibitors and Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisSemantic proximity Read

Demand experience of lymphoma patients with full disease trajectory：A qualitative researchSemantic proximity Read

Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in advanced non-small cell lung cancer: A systematic review of randomized controlled trialsSemantic proximity Read

Analysis of Influence Factors of Quality of Life of Lung Cancer Patients with Skin Adverse Drug Reactions Under Targeted TherapySemantic proximity Read

Real-world Data Analysis of Immunotherapy in Advanced Lung CancerSemantic proximity Read

Efficacy and Safety of Immuno-based Therapy Versus Standard of Care in Extensive-stage Small-Cell Lung Cancer: An Updated Meta-analysis of Randomized Clinical TrialsSemantic proximity Read

Immune Checkpoint Inhibitor without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A real-world retrospective studySemantic proximity Read

Unmet Need and Treatment Expectations of Previously Treated Patients With Epidermal Growth Factor Receptor-Mutated Advanced Nonsmall Cell Lung Cancer: A Qualitative Interview Study.Semantic proximity Read

Perspectives of Cancer Patients and Their Health during the COVID-19 PandemicSemantic proximity Read

Real-World Outcomes and Clinical Heterogeneity of First-Line Immunochemotherapy in Extensive-Stage Small-Cell Lung CancerSemantic proximity Read

Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation.Semantic proximity Read